Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
UroGen Pharma Ltd. (URGN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2023 |
4
| Robinson James A. Jr. (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 20,000 options to buy
@ $8.9, valued at
$178k
|
|
| 06/09/2023 |
4
| Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 30,000 restricted stock units
@ $0 |
|
| 02/28/2023 |
4
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 2,211 options to buy
@ $5, valued at
$11.1k
|
|
| 02/02/2023 |
4
| Barrett Elizabeth A. (CEO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 5,000 restricted stock units
@ $0
Exercised 13,333 restricted stock units
@ $0
Granted 75,000 restricted stock units
@ $0
Granted 125,000 options to buy
@ $10.39, valued at
$1.3M
Granted 100,000 rights
@ $0 |
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Smith Jason Drew (General Counsel) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 409 shares
@ $10.12, valued at
$4.1k
Sold 1,227 shares
@ $10.12, valued at
$12.4k
Exercised 833 restricted stock units
@ $0
Exercised 2,500 restricted stock units
@ $0
Granted 20,000 restricted stock units
@ $0
Granted 40,000 options to buy
@ $10.39, valued at
$415.6k
|
|
| 02/02/2023 |
4
| Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 248 shares
@ $10.12, valued at
$2.5k
Sold 991 shares
@ $10.12, valued at
$10k
Sold 661 shares
@ $10.12, valued at
$6.7k
Exercised 500 restricted stock units
@ $0
Exercised 2,000 restricted stock units
@ $0
Exercised 1,333 restricted stock units
@ $0
Granted 10,000 restricted stock units
@ $0
Granted 30,000 options to buy
@ $10.39, valued at
$311.7k
|
|
| 01/23/2023 |
4
| Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 122,677 options to buy
@ $5, valued at
$613.4k
|
|
| 11/09/2022 |
4
| Wildman Daniel George (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 20,000 options to buy
@ $11.88, valued at
$237.6k
|
|
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2022 |
4
| Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 160,000 options to buy
@ $5, valued at
$800k
|
|
| 09/12/2022 |
4
| WEN LEANA (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 20,000 options to buy
@ $7.73, valued at
$154.6k
|
|
| 09/02/2022 |
4
| Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 3,241 options to buy
@ $5, valued at
$16.2k
|
|
| 09/02/2022 |
4
| Smith Jason Drew (General Counsel) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 3,606 shares
@ $7.21, valued at
$26k
Exercised 8,333 restricted stock units
@ $0 |
|
| 08/25/2022 |
4
| Nussbaum Ran (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 1,030 options to buy
@ $5, valued at
$5.2k
|
|
| 08/25/2022 |
4
| Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 259 shares
@ $7.81, valued at
$2k
Exercised 500 restricted stock units
@ $0 |
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2022 |
4
| Kim Dong (CFO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 30,000 options to buy
@ $8.61, valued at
$258.3k
|
|
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2022 |
4
| Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 111 shares
@ $8.09, valued at
$898
Exercised 209 restricted stock units
@ $0 |
|
| 01/07/2022 |
4
| Barrett Elizabeth A. (CEO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 46,968 shares
@ $9.15, valued at
$429.8k
Exercised 105,689 restricted stock units
@ $0 |
|
| 12/02/2021 |
4
| Smith Jason Drew (General Counsel) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 3,803 shares
@ $12.03, valued at
$45.8k
Exercised 8,333 restricted stock units
@ $0 |
|
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2021 |
4
| Schoenberg Mark (Chief Medical Officer) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Bought 160 shares
@ $13.1, valued at
$2.1k
|
|
|
|
|